Thrombosis Research
2012-10-01
Is there any need for a TAFI(a) inhibitor as thrombolytic drug?
Ellen Vercauteren, Ann Gils
Index: Thromb. Res. 130(4) , 574-5, (2012)
Full Text: HTML
Abstract
Related Articles:
Development of imidazole alkanoic acids as mGAT3 selective GABA uptake inhibitors.
2011-05-01
[Eur. J. Med. Chem. 46 , 1483-98, (2011)]
Surface interactions of a homologous series of alpha,omega-amino acids on colloidal silver and gold.
1999-01-01
[Biospectroscopy 5(1) , 9-17, (1999)]
Specific anionic residues of the recombinant kringle 2 domain of tissue-type plasminogen activator that are responsible for stabilization of its interaction with omega-amino acid ligands.
1993-04-13
[Biochemistry 32(14) , 3540-8, (1993)]
The cationic locus on the recombinant kringle 2 domain of tissue-type plasminogen activator that stabilizes its interaction with omega-amino acids.
1992-12-01
[Biochemistry 31(47) , 11698-706, (1992)]
Intravenous and oral administrations of DD2 [7-Amino-2-(sulfanylmethyl)heptanoic acid] produce thrombolysis through inhibition of plasma TAFIa in rats with tissue factor-induced microthrombosis.
2012-10-01
[Thromb. Res. 130(4) , e222-8, (2012)]